Science Explorer Back to mapMap
Institution · UsAgainstAlzheimer

Most cited papers from UsAgainstAlzheimer

What are the most cited papers from UsAgainstAlzheimer?

The most cited paper from UsAgainstAlzheimer is "Acceptable performance of blood biomarker tests of amyloid pathology — recommendations from the Global CEO Initiative on Alzheimer’s Disease" (Suzanne Elizabeth Schindler et al., 2024), with 296 citations. Next come "Traversing the Aging Research and Health Equity Divide: Toward Intersectional Frameworks of Research Justice and Participation" (110) and "Assessing what matters most to patients with or at risk for Alzheimer’s and care partners: a qualitative study evaluating symptoms, impacts, and outcomes" (83).

Showing 50 of 64 papers. Every paper is listed.

Most cited papers, sortable by citations and release date
#Paper
1 Acceptable performance of blood biomarker tests of amyloid pathology — recommendations from the Global CEO Initiative on Alzheimer’s Disease Suzanne Elizabeth Schindler et al. · Nature Reviews Neurology ReviewOpen access 12 Jun 2024 296
2 Traversing the Aging Research and Health Equity Divide: Toward Intersectional Frameworks of Research Justice and Participation Andrea L Gilmore‐Bykovskyi, Raina L. Croff, Crystal M. Glover et al. · The Gerontologist Open access 27 Jul 2021 110
3 Assessing what matters most to patients with or at risk for Alzheimer’s and care partners: a qualitative study evaluating symptoms, impacts, and outcomes Dana Britt DiBenedetti, Christina Slota, Samantha L. Wronski et al. · Alzheimer s Research & Therapy Open access 30 Jul 2020 83
4 Expanding the use of brief cognitive assessments to detect suspected early‐stage cognitive impairment in primary care Soeren Mattke, Donnie Batie, Joshua Chodosh et al. · Alzheimer s & Dementia Open access 19 Apr 2023 73
5 Primary prevention recommendations to reduce the risk of cognitive decline Marwan Noel Sabbagh, Adriana Pérez, Thomas Monroe Holland et al. · Alzheimer s & Dementia Open access 13 Jan 2022 61
6 Risk of dementia and mild cognitive impairment among older adults in same‐sex relationships Jaime Perales‐Puchalt, Kathryn M. Gauthreaux, Jason D. Flatt et al. · International Journal of Geriatric Psychiatry Open access 13 Mar 2019 47
7 Biometric monitoring devices for assessing end points in clinical trials: developing an ecosystem Stephen P. Arnerić et al. · Nature Reviews Drug Discovery 22 Sep 2017 44
8 The 2018 Revised FDA Guidance for Early Alzheimer's Disease: Establishing the Meaningfulness of Treatment Effects Chris J. Edgar, George Vradenburg, Jason J. Hassenstab · The Journal of Prevention of Alzheimer s Disease Open access Oct 2019 39
9 Integrating Family Caregivers of People With Alzheimer’s Disease and Dementias into Clinical Appointments: Identifying Potential Best Practices Joan M. Griffin, Catherine A. Riffin, Rachel D. A. Havyer et al. · Journal of Applied Gerontology Open access 11 Oct 2019 38
10 Feasibility of an Alzheimer's disease knowledge intervention in the Latino community Jaime Perales‐Puchalt, W. Todd Moore, Cielo Fernández et al. · Ethnicity and Health Open access 18 Feb 2018 32
11 Economic Burden of Alzheimer Disease and Related Dementias by Race and Ethnicity, 2020 to 2060 Stipica Mudražija, María Pilar Lambán Aranda, Darrell J. Gaskin et al. · JAMA Network Open Open access 5 Jun 2025 29
12 Preliminary Efficacy of a Recruitment Educational Strategy on Alzheimer’s Disease Knowledge, Research Participation Attitudes, and Enrollment Among Hispanics Jaime Perales‐Puchalt, Ashley R. Shaw, Jerrihlyn L. McGee et al. · Hispanic Health Care International Open access 15 Dec 2019 27
13 Advancing Inclusive Research: Establishing Collaborative Strategies to Improve Diversity in Clinical Trials Owen Garrick et al. · Ethnicity & Disease Open access 20 Jan 2022 25
14 Assessing What Matters to People Affected by Alzheimer’s Disease: A Quantitative Analysis Brett Hauber et al. · Neurology and Therapy Open access 10 Feb 2023 24
15 A Text Messaging Intervention to Support Latinx Family Caregivers of Individuals With Dementia (CuidaTEXT): Development and Usability Study Jaime Perales‐Puchalt, Mariola Acosta-Rullán, Mariana Ramírez et al. · JMIR Aging Open access 28 Apr 2022 20
16 Technical Review of Clinical Outcomes Assessments Across the Continuum of Alzheimer's Disease Dana Britt DiBenedetti et al. · Neurology and Therapy Open access 15 Feb 2023 18
17 Caregiver appraisals of lucid episodes in people with late‐stage Alzheimer's disease or related dementias Joan M. Griffin, Kyungmin Kim, Joseph E. Gaugler et al. · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring Open access 2022 17
18 Sex Differences in Disorders of the Brain and Heart—A Global Crisis of Multimorbidity and Novel Opportunity Jill M. Goldstein, Ana Langer, Jill A. Lesser · JAMA Psychiatry Open access 8 Jul 2020 16
19 Caring for Dementia Caregivers: Understanding Caregiver Stress During the COVID-19 Pandemic Lee Lancashire, Virginia S. Biggar, Meryl Comer et al. · Gerontology and Geriatric Medicine Open access 2023 15
20 Developing and describing a typology of lucid episodes among people with Alzheimer's disease and related dementias Joan M. Griffin, Kyungmin Kim, Dawn M. Finnie et al. · Alzheimer s & Dementia Open access 2 Feb 2024 14
21 Promoting Healthy Aging: Public Health as a Leader for Reducing Dementia Risk Eva M. J. Jackson, Kelly O’Brien, Lisa C. McGuire et al. · Public Policy & Aging Report Open access 15 Jul 2023 14
22 Promoting diversity in clinical trials: insights from planning the ALUMNI AD study in historically underrepresented US populations with early symptomatic Alzheimer's disease Alexandria Wise-Brown, Sharon A. Brangman, J. Neil Henderson et al. · EClinicalMedicine Open access Jul 2024 13
23 A Delphi Approach to Define Lucid Episodes in People Living With Dementia Lauren R. Bangerter, Joan M. Griffin, Kyungmin Kim et al. · Alzheimer Disease & Associated Disorders Apr 2024 7
24 Development of CuidaTEXT : a text message intervention to support Latino dementia family caregivers Jaime Perales‐Puchalt, Mariola Acosta-Rullán, Mariana Ramírez et al. · medRxiv PreprintOpen access 8 Dec 2021 6
25 Measuring time saved in Alzheimer's disease: What is a meaningful slowing of progression? Krista L. Lanctôt, Linus Jönsson, Alireza Atri et al. · Alzheimer s & Dementia Translational Research & Clinical Interventions Open access Apr 2025 5
26 Opportunities to encourage adoption of a biomarker‐enabled care pathway for Alzheimer's in primary care Soo Borson, Rhoda Au, Anna Haseltine Chodos et al. · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring Open access 2025 5
27 Evaluating Elements of the Care Partner Experience in Individuals Who Care for People with Alzheimer's Disease Across the Severity Spectrum Leigh F. Callahan, Brian J. Samsell, Dana Britt DiBenedetti et al. · Neurology and Therapy Open access 27 Oct 2023 5
28 Care partner evaluation of the behaviors in the Cohen-Mansfield Agitation Inventory Dorothee Oberdhan, Andrew C. Palsgrove, Christy R. Houle et al. · Frontiers in Dementia Open access 8 Mar 2024 4
29 Discussing inconvenient truths about the lack of generalizability of Alzheimer's research to minoritized populations Stephanie J. Monroe · Alzheimer s & Dementia Translational Research & Clinical Interventions Open access Jul 2023 4
30 Measuring What Matters Most to People Living with Alzheimer’s Disease and Care Partners: What Matters Most Quantitative Research Development Carla (DeMuro) Romano, Emily Bratlee‐Whitaker, Ann Hartry et al. · Alzheimer s & Dementia Open access Dec 2024 3
31 Symptoms and Treatment Needs of People with Dementia-Related Psychosis: A Mixed-Methods Study of the Patient Experience Teresa A. Brandt, Theresa Frangiosa, Virginia S. Biggar et al. · Clinical Gerontologist Open access 9 Aug 2021 3
32 Lucid episodes among people with Alzheimer’s disease and related dementias and their impact on family caregiver stress and grief (LEAD): protocol for a longitudinal observational study Joan M. Griffin, Lauren R. Bangerter, Kyungmin Kim et al. · BMJ Open Open access Jul 2025 2
33 Health utilities in Alzheimer's disease: A survey of patients and caregivers in the United States Pei‐Jung Lin, Abigail G Riley, Patricia G. Synnott et al. · Journal of Alzheimer s Disease 19 Jun 2025 2
34 How do we put meaning into meaningful benefit? Perspectives from the lived experience Russ Paulsen, Carla (DeMuro) Romano, Terry L Frangiosa et al. · Alzheimer s & Dementia Translational Research & Clinical Interventions Open access Apr 2025 2
35 Evaluation of what matters most in existing clinical outcomes assessments in Alzheimer's disease Ann Hartry, Heather L. Menne, Samantha L. Wronski et al. · Alzheimer s & Dementia Open access Dec 2020 2
36 A Path to Early Diagnosis of MCI and Dementia: Integrating myMemCheck Into the Primary Care Workflow William E. Mansbach, Ryan A. Mace, Theresa Frangiosa et al. · Innovation in Aging Open access Dec 2020 2
37 The value of patient-focused drug development Allison Martin, Russ Paulsen · Nature Medicine 24 Apr 2026 1
38 Priority Ranking: What Matters Most to People Living with Alzheimer's Disease and Care Partners Carla R. Romano et al. · Alzheimer s & Dementia Open access Dec 2025 1
39 Lucid episodes in people with advanced dementia: characterizing caregiver reports to advance definition and measurement of episodes Joan M. Griffin, Lauren R. Bangerter, Kyungmin Kim et al. · The Gerontologist Open access 10 Nov 2025 1
40 Promoting Healthy Aging to Reduce the Risk of Dementia: A Public Health Imperative. Janelle E. Gore, Benjamin Denno, John D. Omura et al. · PubMed Open access 12 Apr 2023 1
41 Unlocking Workplace Brain Health to Fuel Prosperity and Healthy Longevity Kelly O’Brien · American Journal of Health Promotion Open access 29 Mar 2024 1
42 Free Innovative Tool to Address Memory Concerns and Brain Health for All Communities Brooks Kenny · Alzheimer s & Dementia Dec 2022 1
43 Quantifying what matters most to patients and care partners in Alzheimer's disease Brett Hauber, Russ Paulsen, Leigh F. Callahan et al. · Alzheimer s & Dementia Open access Dec 2020 1
44 The importance of care partner input in Alzheimer’s disease (AD) drug development Tabassum Majid, Russ Paulsen, Leigh F. Callahan et al. · Alzheimer s & Dementia Open access Dec 2020 1
45 P4‐673: FINDINGS FROM THE ALZHEIMER'S DISEASE PATIENT AND CAREGIVER ENGAGEMENT (AD PACE) INITIATIVE'S WHAT MATTERS MOST QUALITATIVE STUDY George Vradenburg, Dana Britt DiBenedetti, Brett Hauber et al. · Alzheimer s & Dementia Open access Jul 2019 1
46 Priorities of people living with Alzheimer's and care partners: What Matters Most? Carla (DeMuro) Romano et al. · Alzheimer s & Dementia Open access Aug 2026 0
47 A pilot study to assess the effect of integrating an automated speech‐based cognitive assessment into a brain health platform on PCP visits Vivian Vasallo, Nicklas Linz, Simona Schäfer et al. · Alzheimer s & Dementia Open access Dec 2025 0
48 Employment Outcomes and Productivity Loss Among Caregivers of Community‐Dwelling Individuals with Alzheimer's Disease Patricia G. Synnott, Joshua T. Cohen, Theresa Frangiosa et al. · Alzheimer s & Dementia Open access Dec 2025 0
49 Health Utilities in Alzheimer's Disease: A Survey of US Patients and Caregivers Pei‐Jung Lin, Abigail G Riley, Patricia G. Synnott et al. · Alzheimer s & Dementia Open access Dec 2025 0
50 Implementing a biomarker‐enabled care pathway to accelerate identification of early‐stage Alzheimer’s disease in primary care Soo Borson, Rhoda Au, Anna Haseltine Chodos et al. · Alzheimer s & Dementia Open access Dec 2024 0

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.